Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$8.59 - $20.77 $40,312 - $97,473
-4,693 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$28.89 - $35.33 $135,580 - $165,803
4,693 New
4,693 $165,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Investment Management Corp Of Ontario Portfolio

Follow Investment Management Corp Of Ontario and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Management Corp Of Ontario, based on Form 13F filings with the SEC.

News

Stay updated on Investment Management Corp Of Ontario with notifications on news.